期刊文献+

重组人SOD2/3杂合酶原核表达及纯化方法的研究 被引量:1

Study on Expression and Purification of Recombinant Human SOD2/3 Heterozyme
下载PDF
导出
摘要 目的摸索工程菌的表达条件并分离纯化,获得高活性的重组人SOD2/3杂合酶(rhSOD2/3)。方法利用含有质粒pET-28a-SOD2/3的工程菌诱导表达rhSOD2/3,考察诱导温度、诱导剂浓度、Mn2+浓度与加入时机对重组酶表达量与活性的影响;利用金属螯合亲和层析纯化rhSOD2/3。结果重组酶的表达量占菌体总蛋白40%~50%,最佳表达温度15℃、诱导剂浓度0.5 mmol/L,Mn2+浓度2.5 mmol/L,表达时间16 h,亲和层析能较好的纯化rhSOD2/3,比活从粗酶液220 U/mgpr提高到930 U/mgpr以上。结论成功获得了rh SOD2/3最适的表达条件及纯化方法。 Objective To obtain high expression of recombinant human SOD2/3 heterozyme(rhSOD2/3) by optimizing the expression condition.Methods The rhSOD2/3 heterozyme was expressed by the recombinant engineering bacteria containing pET-28a-SOD2/3 plasmid.The effects of induction temperature,concentration of inductor and Mn2+,adding time were investigated on the expression amount and activity of rhSOD2/3 heterozyme.Then,the rhSOD2/3 heterozyme was purified using metal chelate affinity chromatography.Results The rhSOD2/3 heterozyme was expressed successfully,accounting for 40 %~50 % of the total proteins.The optimal expression condition was the expression induced by 0.5mmol/L IPTG and 2.5mmol/L Mn2+ at 15℃ for16h.The specific activity of rhSOD2/3 was 220 U/mgpr in crude enzymes,while over 930 U/mgpr after purified by affinity chromatography.Conclusion This study can show the optimized expression condition and purification method of rhSOD2/3 heterozyme.
出处 《食品与药品》 CAS 2011年第11期385-388,共4页 Food and Drug
关键词 SOD2/3杂合酶 表达 纯化 亲和层析 SOD2/3 heterozyme expression purification affinity chromatography
  • 相关文献

参考文献4

二级参考文献40

  • 1蔡完其.罗氏沼虾莫格球拟酵母病的病理研究[J].水产学报,1996,20(1):13-17. 被引量:30
  • 2[1]Yang V C,Linhardt R J,Bernstein H,et al.Purification and characterization of heparinase from Flavobacterium heparinum[ J ].J Biological Chemistry,1985,260:1849-1857.
  • 3[2]Lohse D L,Linhardt R J.Purification and characterization of heparin lyases from Flavobacterium heparinum[ J ].J Biological Chemistry,1992,267:24347-24355.
  • 4[3]Bohmer L H,Pitout M J,Steyn P L,et al.Purification and characterization of a novel heparinase[J].J Biological Chemistry,1990,265:13609-13617.
  • 5[5]Langer R,Linhardt R J.An enzymatic system for removing heparin in extracorporeal therapy[ J].Science,1982,217:261-263.
  • 6[6]Silva M E,Dietrich C P.Structure of heparin:Characterization of the products formed from heparin by the action of a heparinase and a heparitinase from Flavobacterium heparinum[J].J Biological Chemistry,1975,250:6841-6844.
  • 7[7]Miao H Q,Elkin M,Aingorn E.Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides[ J].International Journal of Cancer,1999,83:424-431.
  • 8[8]Sasisekharan R,Moses M,Nugent M.Heparinase inhibits neovascularization[J].Proceedings of the National Academy of Sciences of the United States of America,1994,91:1524-1528.
  • 9[10]陈银.肝素酶Ⅰ在大肠杆菌中的高效重组表达研究[D].北京:清华大学化学工程系,2005.
  • 10[11]Sasisekharan R,Bulmer M,Moremen K W,et al.Cloning and expression of heparinase Ⅰ gene from Flavobacterium heparinum[ J ].Proceedings of the National Academy of Sciences of the United States of America,1993,90:3660-3664.

共引文献11

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部